Indivior Pharmaceuticals Statistics
NASDAQ: INDVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
36.13+0.23 (+0.64%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Indivior Pharmaceuticals by the numbers
Indivior Pharmaceuticals has a market capitalization of $4.26 billion based on 118.03M shares outstanding. Its trailing P/E ratio is 12.9, and its forward P/E is 7.4. The stock trades 1.4% below its 50-day average and 1.1% above its 200-day average.
Average daily trading volume is 2.07M shares, or about $74.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INDV valuation vs. peer median
| Metric | INDV | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.26B | $3.97B | +7% |
| Avg. volume | 2.07M | 1.86M | +11% |
Peer median across 8 companies: EWTX, ABCL, MANE, TLX, DNTH, LEGN, TNGX, VKTX.
Valuation
- Market cap
- $4.26B
- P/E (TTM)
- 12.95
- Forward P/E
- 7.40
- Price / sales (latest FY)
- 3.44
- EPS (TTM)
- $2.79
- Shares outstanding
- 118.03M
Price and trading
- Previous close
- 35.90
- Open
- 35.58
- Day range
- 35.58 – 36.30
- 52-week range
- 22.95 – 42.81
- 52-week change
- +52.32%
- Beta
- —
- Volume
- 1.59M
- Average volume
- 2.07M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 4.26B
- Pe
- 12.95
- Forward Pe
- 7.40
- Eps
- 2.79
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.81
- Week52 Low
- 22.95
- Avg Volume
- 2.07M
- Shares Outstanding
- 118.03M
- Ma50
- 36.65
- Ma200
- 35.74
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -15.60%
- Pct From52w Low
- 57.43%